Technology Transfer and Capacity Building Initiatives
Project Based Training and Fellowship on Development, Production and Access to Diagnostics:
ANDI and the Egyptian Academy for Scientific Research & Technology (ASRT) signed a memorandum of understanding on December 11, 2014 to collaborate in supporting health innovation in Africa through joint projects, training and fellowships for African Scientists. The initiative covers health systems strengthening, research and development for health technologies, manufacturing, and regulatory issues as well as maintenance of research and medical equipment. The first programme under this initiative is a Project Based Training and Fellowship program that will be conducted from November 1st to December 11, 2015.
Through this training, Fellows from different African countries will be taken through the laboratory procedures of developing diagnostic immunoassays and its evaluation, registration and commercialization to be showcased by a schistosomiasis diagnostic kit developed at the Theodor Bilharz Institute (TBRI) in Egypt. The diagnostic kit supports the surveillance, control, and elimination in schistosomiasis infection as well as monitoring of cure. TBRI is an ANDI Centre of Excellence in health innovation dedicated to research on schistosomiasis, a neglected tropical disease causing high morbidity in several African countries. Upon completion of fellowship, participants will develop plans to transfer technology to their respective institutions and countries.
Supporting Pharmaceutical Manufacture and Entrepreneurship in Nigeria (Project Agreement Being Finalized):
The analysis and survey undertaken in Nigeria by ANDI, African Development Bank (AfDB) and South Koreas Science and Technology Policy Institute (STEPI) indicate the urgent need to support selected local manufacturers to meet WHO Good Manufacturing Practice (GMP) standard as well as enhance local entrepreneurship for health technologies. In cognizance of these gaps, ANDI is partnering with AfDB to support capacity of selected Nigerian pharmaceutical manufactures to achieve WHO Good manufacturing Practice (GMP) standards and promote local entrepreneurship for health in Nigeria.
The other part of this project is to foster collaboration amongst three Nigerian institutions that are developing entrepreneurship programmes in health technologies. As part of the program the institutions share lessons through exchange of young scientists engaged in entrepreneurship activities and interact with renowned universities in the west and explore the development of an electronic exchange program
Hand on Training on Good Manufacturing Practice (GMP) Compliance and Quality Management System for Manufacturers and Regulators in Africa:
An analysis and survey undertaken in Tanzania and Nigeria by ANDI, AfDB and STEPI, highlighted the urgent need to support African National Drug regulatory Authorities (NDRAs) and select local manufacturers to comply with Current Good Manufacturing Practice (cGMP) and QMS requirements. In cognizance of these gaps, ANDI promoted this project with the primary objective of training local pharmaceutical manufacturers and regulators in Sub- Saharan Africa on the implementation of effective Quality management system (QMS) for product and production. St. Luke Foudation/Klimanjaro School of Pharmacy (SLF/KSP)- ANDI’s CoE in Drug Manufacturing and Regulatory Training deliver hands on world class training on GMP and QMS. The training aims to fill the identified gaps and provide a framework for a broader implementation of national pharmaceuticals and regulatory plans. The program hopes to contribute in reducing the incidence of counterfeit or substandard drugs in Africa market, which will in turn improve public health and emergence of drug resistance.
ANDI – EMORY Collaboration (Agreement Being Finalized):
To accelerate the development of new medicines, the African Network for Drugs and Diagnostics Innovation (“ANDI”) and Emory University, through its Emory Institute for Drug Development, are partnering to provide a platform for identifying promising new local technologies, advancing the human capacity needed to further those technologies through mentoring and education, and translating the technologies from laboratories to clinics and markets. The program will initially focus on: i) identification, mentorship and training to support the advancement of identified local African technologies in the biopharmaceutical area, and ii) identification of one or two regional technology hub/incubator(s),from existing Centres of Excellence in Africa, that can be strengthened to provide technical support for potential transformative products emerging from African laboratories. The technology hub will be equipped to provide business development as well as project, finance, IP, technology transfer and entrepreneurship support for projects. On the other hand, the same or different regional hub will be equipped to provide targeted contract research support in specific areas such as medicinal chemistry, toxicology, quality assurance, quality control and regulatory etc. While these regional hubs shall operate on a not for profit basis, they are expected to charge a modest fee for the service they provide to support the sustainability of the center once fully operational. This sustainability aspects call for consideration of both grant funding and social venture financing mechanisms which ANDI has been considering. A key feature of the program is that it will leverage global expertise, not just from Emory and ANDI, but also from North America, Europe and other emerging economies of Asia, South America.